Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Cancer Cells Upregulate NRF2 Signaling to Adapt to Autophagy Inhibition.

Christina G Towers | Brent E Fitzwalter | Daniel Regan | Andrew Goodspeed | Michael J Morgan | Chang-Wei Liu | Daniel L Gustafson | Andrew Thorburn
Developmental cell | 2019

While autophagy is thought to be an essential process in some cancer cells, it is unknown if or how such cancer cells can circumvent autophagy inhibition. To address this, we developed a CRISPR/Cas9 assay with dynamic live-cell imaging to measure acute effects of knockout (KO) of autophagy genes compared to known essential and non-essential genes. In some cancer cells, autophagy is as essential for cancer cell growth as mRNA transcription or translation or DNA replication. However, even these highly autophagy-dependent cancer cells evolve to circumvent loss of autophagy by upregulating NRF2, which is necessary and sufficient for autophagy-dependent cells to circumvent ATG7 KO and maintain protein homeostasis. Importantly, however, this adaptation increases susceptibly to proteasome inhibitors. These studies identify a common mechanism of acquired resistance to autophagy inhibition and show that selection to avoid tumor cell dependency on autophagy creates new, potentially actionable cancer cell susceptibilities.

Pubmed ID: 31378590

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Atg5 (D5G3) Rabbit mAb (antibody)

RRID:AB_10829153

This monoclonal targets Atg5 (D5G3) Rabbit mAb

View all literature mentions

Anti-STX17 antibody produced in rabbit (antibody)

RRID:AB_1080118

This polyclonal targets STX17 antibody produced in rabbit

View all literature mentions

Anti-β-Actin Antibody (antibody)

RRID:AB_476744

This monoclonal targets slightly modified β-cytoplasmic actin N-terminal peptide, Ac-Asp-Asp-Asp-Ile-Ala-Ala-Leu-Val-Ile-Asp-Asn-Gly-Ser-Gly-Lys, conjugated to KLH

View all literature mentions

LC3B Antibody (antibody)

RRID:AB_10003146

This polyclonal targets LC3B

View all literature mentions

p62/SQSTM1 Antibody (antibody)

RRID:AB_548364

This monoclonal targets p62/SQSTM1

View all literature mentions

PTEN (A2B1) (antibody)

RRID:AB_628187

This monoclonal targets PTEN

View all literature mentions

Atg7 (D12B11) Rabbit mAb (antibody)

RRID:AB_10831194

This monoclonal targets Atg7 (D12B11) Rabbit mAb

View all literature mentions

Atg12 Antibody (Human Specific) (antibody)

RRID:AB_2059086

This unknown targets Human Atg12

View all literature mentions

Nrf2 antibody [EP1808Y] - Carboxyterminal end (antibody)

RRID:AB_944418

This monoclonal targets Nrf2 antibody [EP1808Y] - Carboxyterminal end

View all literature mentions

Anti-rabbit IgG, HRP-linked Antibody (antibody)

RRID:AB_2099233

This polyclonal secondary targets IgG

View all literature mentions

MCF-7 (cell line)

RRID:CVCL_0031

Cell line MCF-7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NCI-H1650 (cell line)

RRID:CVCL_1483

Cell line NCI-H1650 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

BT-549 (cell line)

RRID:CVCL_1092

Cell line BT-549 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HT-1080 (cell line)

RRID:CVCL_0317

Cell line HT-1080 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SJSA-1 (cell line)

RRID:CVCL_1697

Cell line SJSA-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCT 116 (cell line)

RRID:CVCL_0291

Cell line HCT 116 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NCI-H292 (cell line)

RRID:CVCL_0455

Cell line NCI-H292 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions